Skip to content

ZBIO

Zenas BioPharma, Inc.

NASDAQ · USHealthcareBiotechnology
$29.89+1.24%

Price as of Jul 20, 2026

ZBIO earnings

Zenas BioPharma, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 11, 2026in NaN days
EPS est $-0.89 · Revenue est $15M
Track record
Beat EPS in 1 of 5 quarters
Avg surprise -93.1% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 13, 2026$-1.37$-1.46-6.6%
Mar 16, 2026$-1.00$-4.54-353.4%
Nov 12, 2025$-0.87$-1.22-40.2%
May 15, 2025$-1.11$-0.80+27.9%$10M+700.0%
Mar 25, 2025$-0.92$-3.99-333.7%$5M
Jun 30, 2024$-0.99
Mar 31, 2024$-0.73
Dec 31, 2023$-0.64
Sep 30, 2023$0.85$50M
Jun 30, 2023$-0.76
Mar 31, 2023$-0.50
Dec 31, 2022$-0.50

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.